KAS
MRNA icon

Kestra Advisory Services’s Moderna MRNA Stock Holding History

Kestra Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841K Sell
12,016
-261
-2% -$13.5K ﹤0.01% 1961
2026
Q1 		$624K Buy
12,277
+3,720
+43% +$174K ﹤0.01% 2058
2025
Q4 		$252K Sell
8,557
-139
-2% -$3.78K ﹤0.01% 2687
2025
Q3 		$225K Sell
8,696
-2,369
-21% -$66.1K ﹤0.01% 2657
2025
Q2 		$305K Buy
11,065
+4,492
+68% +$118K ﹤0.01% 2337
2025
Q1 		$186K Sell
6,573
-3,533
-35% -$125K ﹤0.01% 2495
2024
Q4 		$420K Buy
10,106
+1,269
+14% +$60.7K ﹤0.01% 1991
2024
Q3 		$591K Sell
8,837
-2,469
-22% -$227K ﹤0.01% 1664
2024
Q2 		$1.34M Sell
11,306
-934
-8% -$118K 0.01% 1161
2024
Q1 		$1.3M Sell
12,240
-1,804
-13% -$182K 0.01% 1087
2023
Q4 		$1.4M Sell
14,044
-7,284
-34% -$613K 0.01% 963
2023
Q3 		$2.2M Buy
21,328
+8,696
+69% +$970K 0.02% 653
2023
Q2 		$1.53M Sell
12,632
-1,872
-13% -$250K 0.02% 782
2023
Q1 		$2.23M Sell
14,504
-1,933
-12% -$319K 0.02% 610
2022
Q4 		$2.95M Sell
16,437
-203
-1% -$33.2K 0.03% 603
2022
Q3 		$1.97M Sell
16,640
-362
-2% -$54.9K 0.02% 669
2022
Q2 		$2.43M Sell
17,002
-3,112
-15% -$445K 0.03% 602
2022
Q1 		$3.46M Buy
20,114
+2,541
+14% +$428K 0.04% 482
2021
Q4 		$4.46M Sell
17,573
-9,888
-36% -$2.89M 0.05% 409
2021
Q3 		$10.6M Buy
27,461
+5,531
+25% +$2.04M 0.11% 211
2021
Q2 		$5.15M Sell
21,930
-4,754
-18% -$850K 0.06% 354
2021
Q1 		$3.49M Sell
26,684
-3,655
-12% -$530K 0.04% 420
2020
Q4 		$3.37M Buy
30,339
+13,017
+75% +$1.32M 0.04% 431
2020
Q3 		$1.23M Buy
+17,322
New +$1.21M 0.02% 559

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Kestra Advisory Services's MRNA Position: Q2 2026 in Review

Kestra Advisory Services reduced its Moderna (MRNA) stake by 2.1% in Q2 2026, selling an estimated $13.5K and leaving 12,016 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

Kestra Advisory Services first reported a position in MRNA in Q3 2020 and has held it in 24 quarters since. The position peaked at $10.6M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Kestra Advisory Services held 12,016 shares of Moderna worth $841K as of Q2 2026.
  • Kestra Advisory Services sold 261 Moderna shares in Q2 2026, an estimated $13.5K.
  • Moderna made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1961 holding.
  • Kestra Advisory Services first reported a position in Moderna in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's Moderna position peaked at $10.6M in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.